Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • AMIC FORGING LIMITED– SME IPO at BSE SME to open on November 29, 2023 Business
  • Dr. Ekta Vala Chandarana And AOGS Lead the Charge in Breast Cancer Awareness with “Impact” Series Health
  • Housing trends to watch out for in 2022 Business
  • Rain and Revelry Mark the Opening of Saputara Megh Malhar Festival 2024 Lifestyle
  • Komatsu and SMFG India Credit Co. Ltd. Launch Finance Scheme to Empower First-Time Machine Buyers and Small Fleet Owners Business
  • Gopal Dash Baghel: A Visionary Leader in Finance, Administration, and Sports Management, Honored at Times Applaud Inspiring Leaders Awards 2023 Lifestyle
  • Pleo BKC Reveals Chef Nitin Suvarna’s Summer Soiree Menu Bursting with Mango Magic Business
  • BGMI Releases Redeem Codes Featuring Casual Stroll Set and In-Game Rewards Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Chandan Healthcare Limited inaugurates second Diagnostic Centre in Ayodhya Health
  • Why Skinimalism Is More Than a Trend: Dr. Jagdish Sakhiya on the New Face of Skincare Health
  • Understanding Acute Myocarditis in Children: A Rare but Serious Condition Health
  • Gender Dysphoria and Autism – what’s new? Health
  • Optimal Nourishment: The Science of Eating Right with Dietician’s Expert Insights Health
  • In real terms, hemp possesses a multitude of uses in the fields of medicine and health. Health

Recent Posts

  • Lagnam Spintex Reports Strong Q2 & H1 Fy27 Performance; Ebitda Rises 98% In Q2 And 64% In H1fy27
  • PATHVIK Launches to End Career Guesswork: Students Can Now Experience a Career Before They Choose It
  • Celebrating 20 Years of Pioneering India’s Solar Revolution: Orb Energy’s Journey
  • As India’s Top Law Firms Embrace AI, VakilPlus Wants to Bring It to Every Lawyer
  • Onward Technologies Delivers its Strongest-Ever Quarter; Total Revenue up 22.2% and EBITDA up 33.7% YoY; Raises FY27 Outlook

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Hisense India Appoints Pankaj Rana as Chief Executive Officer to Accelerate Growth Business
  • Neha Dhaliwal: A Visionary Leader in Data Science and Automation Transforming Healthcare Innovation Business
  • Inside India’s School Innovation Movement: How RoboSpecies Technologies Is Turning Classrooms into Real-World Problem-Solving Labs Education
  • Kolkata witnessed the culmination of the mega finale event of Jeeo King & Queen Mr./Ms and Mrs India International Season -2 Lifestyle
  • Matrix Entertainment’s Tribute to Extraordinary: “She Inspiring Women Awards” Lifestyle
  • Bank of Maharashtra’s P. Ananya Sree to Represent India in the 2025 AVC Women’s Nations Cup Sports
  • Amrut Software Hosts Successful Amrut Tech Summit’23, Explores Modern Service Management Business
  • Crown Vet Expands its State-of-the-Art Pet Care Services to Hyderabad Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme